Abstract Details

Title Impact of Mutations in Parkin on Mitochondrial Function and Morphology

Topic Neurogenetics and Gene Therapy

Presentation(s) (-)

Poster/Presentation
Number 216

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Adam De Havenon, MD, FAAN (Yale University)	Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Lisa Voges	No disclosure on file
	No disclosure on file
Meike Kasten, MD	No disclosure on file
Norman Kock, MD (Dept of Neurology,Univ of Lueben)	No disclosure on file

��ɫ����